![]() |
市場調査レポート
商品コード
1504161
充填剤製造の市場規模、シェア、予測、動向分析:提供(包装タイプ、装置、サービス)製剤(経口、非経口)用途(生物製剤、低分子)エンドユーザー別-2031年までの世界予測Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User - Global Forecast to 2031 |
||||||
カスタマイズ可能
|
充填剤製造の市場規模、シェア、予測、動向分析:提供(包装タイプ、装置、サービス)製剤(経口、非経口)用途(生物製剤、低分子)エンドユーザー別-2031年までの世界予測 |
出版日: 2024年06月01日
発行: Meticulous Research
ページ情報: 英文 550 Pages
納期: 5~7営業日
|
充填仕上げ製造市場は2031年までに191億4,000万米ドルに達すると予測され、2024年から2031年までのCAGRは9.9%と予測されています。
本レポートは、広範な2次調査と1次調査、および充填仕上げ製造市場シナリオの詳細な分析を経て、主要な業界促進要因、抑制要因、課題、および機会の分析で構成されています。充填仕上げ製造市場の成長は、バイオ医薬品産業の成長、製薬・バイオ医薬品企業による生産能力拡大への取り組み、充填仕上げ製造プロセスの進歩、プレフィルドシリンジの需要増加が原動力となっています。しかし、運用コストの高さや、製造工程全体を通じて薬剤の効能を維持する上での課題が、市場の成長を抑制する可能性があります。
さらに、ワクチン接種率の向上を目指した取り組み、バイオシミラー開発への注力の高まり、新規生物製剤開発への投資の増加は、市場成長の機会を生み出すと予想されます。しかし、充填仕上げ製造に関する厳しい規制要件や、特定の投薬量を正確に充填することに伴う複雑さは、市場の成長を阻害する課題の一部です。
(注:上位5社のSWOT分析を掲載)
Fill-finish Manufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Packaging Type {Vial, Syringe, Cartridge} Equipment, Service) Formulation (Oral, Parenteral) Application (Biologics, Small Molecule) End User-Global Forecast to 2031
The Fill-finish Manufacturing Market is Projected to Reach $19.14 Billion by 2031, at a CAGR of 9.9% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the fill-finish manufacturing market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the fill-finish manufacturing market is driven by the growth of the biopharmaceutical industry, initiatives by pharmaceutical & biopharmaceutical companies to expand their production capacities, advancements in fill-finish manufacturing processes, and the increasing demand for pre-filled syringes. However, high operational costs and challenges in maintaining drug potency throughout the manufacturing process may restrain the market's growth.
Moreover, initiatives aimed at increasing vaccination rates, increasing focus on biosimilar development, and rising investments in the development of new biologics are expected to create market growth opportunities. However, stringent regulatory requirements governing fill-finish manufacturing and the complexities associated with accurately filling specific medication doses are some of the challenges impeding the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the fill-finish manufacturing market are Syntegon Technology GmbH (Germany), Becton, Dickinson and Company (U.S.), Industria Macchine Automatiche S.p.A. (Italy), West Pharmaceutical Services, Inc. (U.S.), Catalent, Inc. (U.S.), AbbVie Inc. (U.S.), Gerresheimer AG (Germany), AptarGroup, Inc. (U.S.), OPTIMA packaging group GmbH (Germany), Baxter International Inc. (U.S.), C.H. Boehringer Sohn AG & Co. KG (Germany), Schott Pharma AG & Co. KGaA (Germany), SGD Pharma (France), and Stevanato Group (Italy).
Among the offerings covered in this report, in 2024, the packaging type segment is expected to account for the largest share of the fill-finish manufacturing market. The packaging type segment is further sub-segmented into vials, syringes, cartridges, ampoules, and accessories. The large market share of this segment is attributed to the increasing approval for biologics, increasing demand for parenteral formulations, recurring demand for fill-finish packaging, and advancements in fill-finish technology. Additionally, there is an increasing demand for fill-finish services is increasing for vials, cartridges, and other packaging types to reduce product wastage and maintain sterility while filling the drug.
Among the formulations covered in this report, in 2024, the parenteral segment is expected to account for the largest share of the fill-finish manufacturing market. Vials, syringes, cartridges, and ampoules are commonly used for the packaging of parenteral drug formulations. The increasing demand for injectables, technological advancements in materials, and designs of pre-fillable syringes and vials are contributing to the large market share of this segment. Additionally, the increasing number of approvals for injectables is further contributing to the segment growth. For instance, in September 2023, Pfizer Inc. (U.S.) and BioNTech SE (Germany) obtained supplemental Biologics License Application approval from the U.S. FDA for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine.
Among the sterilization processes covered in this report, in 2024, the aseptic processing segment is expected to account for the largest share of the fill-finish manufacturing market. The demand for aseptic processing is driven by the need to sterilize heat-sensitive drugs such as biologics, vaccines, and other parenteral medications. Moreover, there is a growing demand for aseptic processing for handling heat-sensitive drugs such as antibiotics, nasal sprays, ear drops, oral drops, and diabetes medications.
Among the applications covered in this report, the biologics segment is projected to register a higher CAGR during the forecast period. The segment's rapid growth can be attributed to the rising demand for biologics, expansion of biologics manufacturing facilities, rising approvals for biologic products, and product launches by key market players. For instance, in June 2023, UCB (Belgium), a biopharmaceutical company, received U.S. FDA approval for RYSTIGGO (rozanolixizumab-noli) under Priority Review designation for the treatment of generalized myasthenia gravis (gMG) in adult patients.
Among the end users covered in this report, in 2024, the CROs & CDMOs segment is expected to account for the largest share of the fill-finish manufacturing market. The surge in clinical trials and rapid growth in the healthcare and life sciences sectors are accelerating the outsourcing trend to ensure efficient and cost-effective drug filling. Additionally, strategic partnerships between pharmaceutical companies and CROs & CDMOs and stringent regulatory requirements governing fill-finish processes are contributing to the largest share of the segment.
An in-depth analysis of the geographical scenario of the global fill-finish manufacturing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of over 11.3% during the forecast period. The growth of this regional market is driven by the growth of the pharmaceutical market, increasing investments in R&D by pharmaceutical & biopharmaceutical companies, and favorable regulatory policies. Additionally, China has become an attractive destination for international pharmaceutical companies seeking to streamline product timelines and minimize production costs.
Fill-finish Manufacturing Market Assessment-by Offering
Note: Other Materials include rubber, metal, and paper.
Other Packaging Instruments include powder sachet filling & packaging equipment, nested filling systems, tube filling equipment, and cream filling equipment.
Other Packaging Services include capsule filling, tube filling, sachet filling, and powder filling.
Fill-finish Manufacturing Market Assessment-by Formulation
Note: Other Formulations include nasal, ocular, intradermal, and transcutaneous (TC) formulations
Fill-finish Manufacturing Market Assessment-by Sterilization Process
Fill-finish Manufacturing Market Assessment-by Application
Fill-finish Manufacturing Market Assessment-by End User
Fill-finish Manufacturing Market Assessment-by Geography
(Note: SWOT Analyses of the Top 5 Companies Will Be Provided.)